| Literature DB >> 12460901 |
Courtney L Scaife1, Jinqiu Kuang, Jason C Wills, D Brad Trowbridge, Phil Gray, Bernadette M Manning, Ernst J Eichwald, Raymond A Daynes, Scott K Kuwada.
Abstract
The transcription factor nuclear factor kappaB (NFkappaB) is constitutively active in many types of cancercells and regulates the expression of several antiapoptotic genes. Previous studies demonstrated a role for the inhibition of NFkappaB in cancer therapyusing a transgenic approach in mice. We found that NFkappaB was transiently activated much greater than background constitutive levels during colon cancer cell readhesion, which rendered the readhering colon cancer cells exquisitely susceptible to apoptosis in the presence of soluble NFkappaB inhibitors. These compounds greatly reduced colon cancer cell implantation in an in vivo seeding model of metastasis. The ability of soluble NFkappaB inhibitors to significantly induce apoptosis of readherent colon cancer cells makes them prospective candidates for preventing colon cancer metastasis.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12460901
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701